Direxion Daily Financial Bull 3X Shares ETF
FAS
Ultra Financials Proshares
UYG
Spdr S&P Bank Etf
KBE
4
SPDR S&P Metals & Mining ETF
XME
5
SPDR S&P Retail ETF
XRT
US Stock MarketDetailed Quotes
Imunon (IMNN)
- 3.890
- +0.010+0.26%
Trading Dec 17 15:42 ET
11.94MMarket Cap-0.25P/E (TTM)
4.000High3.830Low12.59KVolume3.830Open3.880Prev Close48.98KTurnover0.41%Turnover RatioLossP/E (Static)3.07MShares41.21752wk High2.93P/B11.81MFloat Cap3.56052wk Low--Dividend TTM3.04MShs Float1895135.869Historical High--Div Yield TTM4.38%Range %3.560Historical Low3.892Avg Price1Lot Size
IMNN Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
IMNN Orderflow
Unit: --
IMNN Orderflow Trend
IntradayDayWeekMonth
No Data
Imunon (IMNN) News
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
Alliance Global Partners Remains a Buy on Imunon (IMNN)
A. G. P. Maintains Imunon(IMNN.US) With Buy Rating, Cuts Target Price to $12
Imunon, Inc. Earnings Call Highlights Progress and Challenges
Earnings Call Summary | Imunon(IMNN.US) Q3 2025 Earnings Conference
Imunon Targets Full OVATION 3 Enrollment by Late 2028 While Accelerating Site Activation and Advancing IMNN-001
Imunon (IMNN) Stock Forum
1
$Imunon (IMNN.US)$ Fantastic news
$Imunon (IMNN.US)$ IMUNON Presents IMNN-001 Phase 2 Translational Data In Ovarian Cancer; Results Showed 13-Month Increase In Overall Survival
Benzinga
just
Benzinga
just
3
$Imunon (IMNN.US)$
IMUNON (NASDAQ: IMNN) presented promising new translational data from its Phase 2 OVATION 2 Study of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The study, involving 112 participants, demonstrated significant improvements in the tumor micro-environment (TME) through the local administration of IL-12 immunothe...
IMUNON (NASDAQ: IMNN) presented promising new translational data from its Phase 2 OVATION 2 Study of IMNN-001, a DNA-mediated immunotherapy for advanced ovarian cancer. The study, involving 112 participants, demonstrated significant improvements in the tumor micro-environment (TME) through the local administration of IL-12 immunothe...
1
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
103128768 : This type of company hardly share price boom by revenue. Normally investors only excited on it study result.